Important Dates for Abstract Submission
- Abstract Submission Opens: Tuesday, 01st July 2025
- Abstract Submission Deadline: From: 1st October 2025, midnight IST (23:59)
To: 30th November 2025, midnight (23:59 IST) - Abstract Notifications: 30th November 2025
Before submitting, please review the guidelines below.
All abstracts must be submitted online only.
All abstracts must be submitted online only.
- ● Read the full Abstract Submission Guidelines before proceeding.
- ● All submissions must be made via the Congress submission system.
- ● Ensure all authors/presenters are aware of, and agree with, the abstract details as well as the submission terms and conditions.
- ● No changes or transfer of registration will be allowed once an abstract is submitted.
Abstract Topics
OSSICON 2026 welcomes submissions on a wide range of topics in bariatric and
metabolic surgery, clinical research, nutrition, technology, and more.
View Full List of Abstract Topics
- ● Before submitting, the presenting author must ensure that all co-authors are aware of, and agree to, the abstract details as well as the submission terms and conditions. Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
- ● The acceptance of an abstract does not imply the provision of travel, accommodation, or registration for the Congress, nor any other costs associated with the preparation, presentation of the oral or ePoster, or any costs associated with attendance at the Congress.
- ● Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the deadline indicated in the notification email will be able to present their study at the Congress and to make sure their abstract is included in the Abstract Book that will be published in Obesity Surgery.
- ● By submitting your abstract, you agree to have your abstract (if accepted) published on the Congress website, Congress app and in printed material.
- ● By submitting an abstract, you give permission to film or photograph your presentation at the Congress.
- ● The Abstract Submitter grants the Organizers a royalty-free, perpetual, irrevocable, nonexclusive license to use, reproduce, publish, translate, distribute, and display the content.
- ● Disclosure of Conflicts of Interest: If you have any commercial interests or associations that might pose a conflict of interest regarding the submission, they must be declared in the submission system. If accepted for presentation, the commercial interest or association must be declared on the title slide or the slide immediately following the title slide.
- ● If the presenting author is unable to attend or present, they must immediately notify the Secretariat at info@ossicon2026.com. A change of presenter must be communicated and approved.
- ● Use first-person language: “people with obesity” not “obese”.
- ● Use “severe obesity” (or reference BMI range or Class), never “morbid obesity”, etc.
- ● Do not use words such as: “success/failure”, “recidivism”, “non-compliant”, “gold-standard”, “last-resort”.
- ● Avoid the term “weight-loss surgery”; use “bariatric-metabolic surgery”.
- ● Imagery: do not use headless people, stereotypes, fast food, ill-fitting clothes, etc.
| Old and Not Accepted | New Replacement Nomenclature |
| Morbid obesity | Severe obesity |
| Obese/Diabetics | Patient or individual with obesity/diabetes |
| Subject/s | Patient/s or individual/s |
| Weight loss surgery | Metabolic Bariatric Surgery (MBS) |
| Super or super-super obesity | Use BMI reference >50 or >60 |
| Gold standard | Avoid using this term please |
| Revision procedure | Revision or modification |
| Conversion procedure | Conversion |
| Reversal procedure | Reversal |
| Insufficient or inadequate weight loss | Suboptimal clinical response |
| Weight loss failure | Suboptimal clinical response |
| Adequate weight loss | Optimal clinical response |
| Success | Optimal clinical response |
| Restrictive or Malabsorptive procedures | Anatomic description |
| Malabsorption/Hypoabsorption | Specify micronutrients/macronutrients |
| Weight regain/recurrence | Recurrent weight gain |
BMI Categories:
- ● BMI 30 <35 kg/m² – Obesity I
- ● BMI 35 <40 kg/m² – Obesity II
- ● BMI 40 <50 kg/m² – Obesity III
- ● BMI 50 <60 kg/m² – Obesity IV (instead of “Super Obesity”)
- ● BMI 60 <70 kg/m² – Obesity V (instead of “Super-Super Obesity”)
Before you begin, please read the Abstract Submission Important Information and then prepare the following information:
- ● Presenting author’s contact details:
- – Full first and family name(s)
- – Email address
- – Affiliation details: department, institution / hospital, city-state (if relevant), Country
- – Phone number
- ● Author and co-authors’ details
- ● Presentation Preference: Oral Presentation / ePoster / Video
Abstract Content
All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-specific publications office (or another similar facility), or by a copy editor prior to submission.
The author is responsible for the accuracy of the abstract.
- ● Abstract title - must be in UPPER CASE and limited to 20 words. Please submit symbols as words.
- ● Abstract text – limited to 350 words, including acknowledgments. (Please Note: word count is affected when graphs/tables are included). Abstracts must contain original scientific data collected by the author(s). Do not include references in your abstract body.
- ● Abstract topic – select the abstract topic per the list of topics.
- ● Tables – a maximum of 2 tables can be incorporated and placed anywhere in the abstract.
- ● Images – The abstract can incorporate a maximum of 2 images. Each image’s maximum file size is 500 KB, and the graph/image’s maximum pixel size is 600(w) x 800(h) pixels. You may upload images in JPG, GIF, or PNG format. Note that images don’t affect the word count.
- ● Abstract Format - Abstracts need to be structured under the following
sub-headings. The abstract should not repeat the title, authors and affiliations
- o Background
- o Objectives
- o Methods
- o Results
- o Conclusion
- ● • Video Submissions - The video should be prepared as follows:
- o We recommend creating the link using Vimeo Link.
- o For instructions, please click here
- o Videos must include verbal narration in English.
- o Narration must use generic terms, and videos cannot contain any evidence of commercial support.
- o Acceptable video format: .mp4
- o Maximum length of the video: 5 minutes
- o Maximum size of the video: 500 MB
- o Videos must be uploaded in HD, in order to assure the best quality possible. The minimum dimensions accepted are 1280×720 (720p); 1920×1080 (1080p). We advise not to compress the file but leave it in the original format. Please do not exceed the maximum length of 60 FPS.
- o Videos should be in a standardized format:
- • Video title
- • Disclosure
- • Clinical presentation and indication for surgery
- • Preoperative x-ray images/endoscopy/blood results
- • Operative procedure
- • Postoperative outcome
- • Conclusions
- o Do not include the name(s) of the author(s) in the video to guarantee blinded review.
- o Ensure that the link is fully accessible and remains this way for at least 3 months after the OSSICON 2026 Meeting if accepted for presentation.
- ● Use only standard abbreviations. Special or unusual abbreviations should be placed in parentheses after the full word the first time they appear.
- ● Use generic names of drugs. If you have any commercial interests or associations that might pose a conflict of interest regarding the submission, they must be declared. If accepted for presentation, the commercial interest or association must be declared on the title slide or the slide immediately following the title slide.
- ● Submissions may not contain patient names, hospital ID numbers, or other identifying information.
- ● Click the SUBMIT button at the end of the process to submit your abstract. After the deadline, abstracts cannot be modified or corrected.
- ● After you submit your abstract, you will receive a confirmation via email.
- ● Please contact us if you have not received confirmation that your abstract has been submitted.
- ● Please do not submit multiple copies of the same abstract.
During abstract submission, you will be asked to confirm that you agree to the
following::
- ● I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after the final submission, and I am aware that it will be published exactly as it was submitted.
- ● Submission of the abstract constitutes the consent of all authors to publication (e.g. Congress website, programs, other promotions, etc.)
- ● The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to OSSI 2026 (Hereafter: the “Organizers“), nor the publication of any such Content by the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to intellectual property rights.
- ● The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
- ● I hereby confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
- ● I understand that the presenting author must be a registered participant.
- ● The Organizers reserve the right to remove an abstract that does not comply with the above from publication and/or presentation.
- ● I understand that I must select a specific Theme, Topic, and/or Sub-Topic for my abstract allocation. Although the Committee will work hard to honor this selection, this cannot be guaranteed. The Committee reserves the right to change the Theme, Topic, or Sub-Topic under which the abstract was originally submitted.
- ● I confirm to have received the consent of all authors for the processing of their contact details by the Organizers.
Originality Disclosure
WITHDRAWAL
- Submitted abstracts/cases should not have been published in any other journals and/or online publications nor presented at any previous international congress.
- Submitting or presenting an already published work will lead to:
-
- ● Withdrawal of the presentation from the Scientific Sessions
- ● Prohibition of submitting abstracts to any OSSI Congress for one year
- Submitted abstracts must report new information, not previously published, or presented at a national or international scientific meeting prior to the Congress. Abstracts previously presented at meetings will not be accepted unless there is a substantial update of data.
- Identified duplicates will be retracted from all related OSSI publications and scientific sessions.
WITHDRAWAL
- Authors will be notified of acceptance/rejection of their abstracts by Mid-November 2025. If an author so desires , they will have a week from the decision notification date to withdraw their abstract from the proceedings.
- NO SHOW
- Please inform the Congress Office if you are no longer able attend the Congress to present your abstract. In case of a no-show, without written justification to info@ossicon2026.com before the start of the Congress, the author will receive a suspension from participation in the next two OSSICON.